Roundhill Investments Launches GLP-1 & Weight Loss ETF
Roundhill Investments Launches GLP-1 & Weight Loss ETF
朗德希爾投資推出 GLP-1 和減肥ETF
OZEM provides exposure to the rapidly growing weight loss management market, which is expected to reach $100 billion by 2030.
OZEm提供了對快速增長的減重管理市場的曝光,預計到2030年將達到1000億美元。
NEW YORK, May 21, 2024 /PRNewswire/ -- Roundhill Investments, an ETF sponsor focused on innovative financial products, is pleased to announce the launch of the Roundhill GLP-1 & Weight Loss ETF (OZEM), which began trading on Nasdaq today. OZEM is the world's first ETF focused exclusively on the rapidly growing sector of GLP-1 receptor agonists and other weight management drugs.
紐約,2024年5月21日/美通社/--ETF發行人Roundhill Investments專注於創新金融產品,欣然宣佈推出Roundhill GLP-1&減重ETF(OZEM),該ETF今天開始在納斯達克上市交易。OZEm是世界上第一個專注於增長迅速的GLP-1受體激動劑和其他減重藥物板塊的ETF。